pharmaceuticals
pharmaceuticals Articles
Proteostasis Therapeutics expects to price less than 4 million shares in the range of $12 to $14 apiece in an initial public offering valued up to around $62 million.
Published:
Last Updated:
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.
Published:
Last Updated:
Corvus Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Reata Pharmaceuticals has amended filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating with a $39 price target.
Published:
Last Updated:
Regeneron Pharmaceuticals reported disappointing fourth-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
If you ever want to look for value in a sector in the stock market, then when you see Congress calling in some of the top companies to scold them for political purposes, you may want to start buying.
Published:
Last Updated:
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
Published:
Last Updated:
Over the past week, Alere and a few biotech other companies made absolutely massive runs, either up and down.
Published:
Last Updated:
Mapi Pharma expects to price more than 3 million shares in the range of $15 to $17 in an initial public offering valued up to about $61 million.
Published:
Last Updated:
Therapure Biopharma has announced that, due to current conditions in capital markets, it would postpone its initial public offering.
Published:
Last Updated:
Sinovac Biotech Ltd. (NASDAQ: SVA) was riding high early Thursday morning, following the offer for a potential buyout, but it looks like this company doesn’t want to take the bait. It announced...
Published:
Last Updated:
Merck reported mixed fourth-quarter financial results before the markets opened Wednesday.
Published:
Last Updated:
In its IPO, Beigene plans to offering more than 5 million American depositary shares in an expected price range of $22 to $24 apiece.
Published:
Last Updated:
Pfizer reported better-than-expected fourth-quarter and full-year 2015 results before markets opened Tuesday morning.
Published:
Last Updated: